Business Overview - Insteel Industries is the nation's largest manufacturer of steel wire reinforcing products for concrete construction applications[6] - In 2019, Welded Wire Reinforcement (WWR) accounted for 64% of sales, while PC Strand accounted for 36%[5] - Nonresidential construction represents 85% of sales, while residential construction accounts for 15%[9] - Concrete product manufacturers account for 70% of sales, while distributors, rebar fabricators, and contractors make up 30%[10] Growth Strategy - Continued conversion of rebar users to Engineered Structural Mesh (ESM) represents a substantial growth opportunity[26] - Focused on pursuing additional strategic acquisition opportunities in existing core businesses[29] Financial Performance - Net sales for fiscal year 2019 were $447.5 million[37] - Raw materials accounted for 74% of the 2019 cost of sales[39] - Capital expenditures are expected to total up to $17.0 million in 2020[55] - As of September 28, 2019, Insteel was debt-free with $38.2 million of cash[58] Market Outlook - Public construction spending for August YTD 2019 was up 5.7% from the prior year[64] - Public highway and street construction spending for August YTD 2019 was up 10.8% from the prior year[67] - Total nonresidential building construction is forecasted to grow 3.8% in 2019 and 2.4% in 2020[70]

智通财经APP获悉，纽约金融市场近期呈现新动向：海外资产管理机构与养老金正加速构筑美元疲软防 火墙，旨在规避美国股市投资组合因汇率波动遭受双重冲击。这种防御性布局源于美元走势与美股表现 的关联性突变当美元指数因特朗普政府4月2日宣布的全球关税政策重挫6.5%、创三年新低时，传统认 知中"美股下跌时美元走强提供缓冲"的避险逻辑出现裂痕，迫使投资者重新审视货币风险对冲策略。 数据印证着市场情绪的微妙变化：罗素投资统计显示，过去12个月MSCI美国指数的欧元对冲版本实现 零收益，而未对冲版本暴跌8.3%，同期美元兑欧元汇率重挫13%。这种汇率损耗直接冲击着持有30万亿 美元美国证券(含17万亿美股、12万亿美债)的海外投资者。BNY Markets宏观策略师维利斯观察到，美 元远期合约抛售量创四年新高，即便面临关税政策波动或地缘冲突可能引发的美元反弹，投资者仍选择 用脚投票。 这场静默的货币保卫战中，外汇衍生品成为核心武器：资产管理人通过远期合约抛售美元兑欧元、英镑 等基础货币，辅以期权工具构筑风险屏障。当美元贬值时，这些对冲头寸的价值攀升恰好抵消股票组合 的汇率损失。正如MillTech基金解决方案主管麦肯纳所言 ...

Business Overview - Insteel Industries is the largest U S manufacturer of steel wire reinforcing products for concrete construction applications[5] - Nonresidential construction accounts for 85% of sales, while residential construction accounts for 15%[7] - Concrete product manufacturers represent 70% of sales, with distributors, rebar fabricators, and contractors making up the remaining 30%[8] Growth Strategy - Insteel acquired Strand-Tech Manufacturing (STM) in March 2020 for $194 million[29] - The company expects to recover approximately $8 million of investment through the closure and sale of the Summerville facility[29] - The company is focused on pursuing additional strategic opportunities in existing core businesses or related products sold into same markets that offer substantial synergy potential[26] Trade Cases - PC strand imports represented around one-third of the U S market in 2019[33] - Alleged dumping margins for PC strand range from 24% to 194%[33] - Filings covered 89% of 2019 import volume[33] - Alleged dumping margins for SWWR range from 56% to 160%[33] - Filings cover practically 100% of 2019 import volume in Insteel's market area[33] Financials - Capital expenditures are expected to total up to $20 million in fiscal year 2021[55] - As of October 3, 2020, Insteel was debt-free with $687 million of cash and no borrowings outstanding on its $100 million revolving credit facility[58]

一个机械手一次就能抓取12个丝饼，然后快速而精准地放至全自动生产线上，经传送、洗涤、烘 干、分级、包装、装箱，销往海内外市场…… 在吉林化纤集团有限责任公司（以下简称"吉林化纤"）今年投产的年产3.5万吨生物质新型人造丝 生产车间，鲜有工人的身影，自动化装置节约了大量人力。 王宏介绍，在吉林化纤，每个党支部都有创新课题，每名党员都承担创新任务，通过发挥基层党组 织和党员的创新传导作用，提高集团全员的创新意识和能力，切实将党的政治优势、组织优势转化为企 业的发展优势。 "我们不断创造适宜的创新平台载体，让党员骨干冲在前面发挥先锋模范作用，带动职工的工作积 极性。"吉林化纤集团党委副书记王宏说。 规格为3K的小丝束碳纤维，主要应用于航空航天、医疗器械、运动器材等领域，市场需求旺盛。 为更好满足下游客户需求，吉林化纤国兴碳纤维公司碳化一车间在党支部的带领下集中攻坚，通过对设 备机器、加工原料、操作方法等要素的分析，先后制定124项攻关措施并逐个突破。 经过近一个月的努力，今年2月改进完成的3K碳纤维新生产线，不仅提产提效，还实现节能降耗。 3K碳纤维价格涨上去了，在市场上很抢手。 长丝十二车间党员王天翼所在的党小组 ...

Ohtuvayre® Commercial Performance and Opportunity - Ohtuvayre® Q1 2025 net sales reached approximately $71 million[7, 9, 56], with approximately 25,000 prescriptions filled[7, 32], and approximately 5,300 unique writers since launch[7, 55] - Ohtuvayre® launch has seen outstanding uptake, with approximately $114 million in net sales in the first 8 months[30] - Ohtuvayre® Q1 2025 dispensed prescriptions showed approximately 60% were refills[32, 55] - The company has approximately $401 million in cash and cash equivalents as of Q1 2025[9, 56] - Approximately 86 million maintenance-treated COPD patients represent a significant market opportunity for Ohtuvayre®[33, 45, 49] Pipeline Expansion and Clinical Development - The company is developing Ensifentrine for non-cystic fibrosis bronchiectasis, targeting approximately 370,000 US patients[16] - Phase 3 data for Ensifentrine showed an approximately 36% to 43% reduction in exacerbation rate compared to placebo[15] - The company is progressing activities for potential marketing authorization submissions, with Phase 3 data expected in Q2[51] Patent Protection and Market Strategy - The company has patent protection through the mid-2030s, with potential patent term extension on select patents[52, 53] - The company is focusing promotional efforts on approximately 8,500 offices, targeting approximately 12,000 HCPs[42, 43] - The company is pursuing strategic collaborations to maximize Ensifentrine's commercial value in regions outside the United States[47]

Business Overview - Insteel Industries is the largest U S manufacturer of steel wire reinforcing products for concrete construction applications[5] - Nonresidential construction accounts for 85% of sales, while residential construction accounts for 15%[7] - Concrete product manufacturers make up 70% of sales, with distributors, rebar fabricators, and contractors accounting for the remaining 30%[8] Competitive Position and Growth Strategy - The company is the largest domestic producer of WWR and PC strand with a national market presence[20] - A growth strategy involves converting rebar users to ESM, which requires fewer tons of steel due to its higher yield strength (80,000 PSI for ESM versus 60,000 PSI for rebar)[23] - Strategic acquisitions, such as Ivy Steel & Wire for $503 million and American Spring Wire for $335 million, are a key part of the growth strategy[25] Financial Performance - The company was debt-free with $898 million of cash and no borrowings outstanding on its $1000 million revolving credit facility as of July 3, 2021[50] - Capital expenditures are expected to total up to $200 million in fiscal year 2021[47] - Public construction spending for May YTD 2021 was down 71% from the prior year and up 60% from the four-year prior average[56] - Private nonresidential construction for May YTD was down 95% from the prior year and down 40% from the four-year prior average[56] - Private residential construction for May YTD was up 238% from the prior year and up 330% from the four-year prior average[56]

Investor Presentation October 21, 2021 Forward-Looking Statements 2 This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. When used in this presentation, the words "believes," "anticipates," "expects," "estimates," "appears," "plans," "intends," "may," "should," "could" and similar expressions are intended to identify forward-looking statements. Although we believe that our plans, intentions and expecta ...

INDUSTRIES INC. Investor Presentation January 20, 2022 Quant Roll 2017 NE r B Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. When used in this presentation, the words "believes," "anticipates," "expects," "estimates," "appears," "plans," "intends," "may," "should," "could" and similar expressions are intended to identify forward-looking statements. Although we believe t ...

Group 1 - The A-share market saw active performance in marine biopharmaceutical concept stocks, with companies like Chengyi Pharmaceutical, Haiwang Biological, and Dongfang Ocean hitting the daily limit up [1] - The Central Financial Committee emphasized the promotion of a unified national market and the high-quality development of the marine economy [1] - Chengyi Pharmaceutical, as the first listed company in Zhejiang focusing on marine biopharmaceuticals, has a revenue share of nearly 70% from this sector [1] Group 2 - Chengyi Pharmaceutical is leveraging its core businesses of glucosamine and fish oil to establish a strong presence in the marine biopharmaceutical field [1] - The company's key product, hydrochloride glucosamine, is derived from chitin sourced from crab and shrimp shells, offering unique advantages such as being all-natural and additive-free [1] - Chengyi Pharmaceutical has developed a full-chain integration advantage in glucosamine products, from raw material extraction to production [1] Group 3 - Dongfang Ocean is also gaining market attention, focusing on marine seed breeding, aquatic product processing, and biotechnology [2] - The company has established a leading position in sea cucumber farming and fish seed breeding, collaborating with institutions like the Chinese Academy of Sciences and Ocean University of China [2] - Dongfang Ocean is advancing its health industry development by establishing platforms for immune technology, mass spectrometry, molecular technology, and third-party medical testing laboratories [2]

Group 1 - The domestic futures market for non-ferrous metals saw significant gains, with polysilicon futures main contract opening at 33,350.0 CNY/ton and reaching a high of 34,650.0 CNY, marking a 5.27% increase [1] - New Lake Futures indicates that there is an expectation of increased production of silicon materials within the month, but the overall market remains weak with a tendency towards a loose supply-demand relationship [1] - The supply side is currently operating at reduced capacity across all polysilicon manufacturers, while demand from downstream photovoltaic components has weakened, leading to a decrease in production plans for battery manufacturers [2] Group 2 - The market sentiment is beginning to improve due to the issuance of photovoltaic desertification plans in the northern desert regions, although polysilicon inventory remains high and is exerting downward pressure on market prices [2] - The recent market dynamics show mixed signals with increased production expectations during the flood season, but the demand is expected to decline significantly in the second half of the year after the end of the installation rush [3] - Overall, the market is facing significant pressure on the demand side, with a cautious purchasing attitude prevailing among end-users following the end of the "rush installation" trend [2][3]